Molecular basis underlying the poly C binding protein 1 as a regulator of the proximal promoter of mouse μ-opioid receptor gene

Brain Research

Volumn 1112, Issue 1, 2006, Pages 33-45

  Malik, Adnan K ^a   Flock, Kelly E ^a   Godavarthi, Chaitanya L ^a   Loh, Horace H ^b   Ko, Jane L ^a  

^a SETON HALL UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

KH domain; Mouse MOR gene; Poly C binding protein 1; Proximal promoter; Single stranded DNA element; Variable domain

Indexed keywords

DNA BINDING PROTEIN; MU OPIATE RECEPTOR; POLYCYTIDYLIC ACID; POLYCYTIDYLIC ACID BINDING PROTEIN 1; REGULATOR PROTEIN; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR GENE; SEQUENCE ANALYSIS; TRANSACTIVATION;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; METHIONINE; MICE; NEUROBLASTOMA; PHOSPHORUS ISOTOPES; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, OPIOID, MU; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 33748448240     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.07.019     Document Type: Article

References (62)

1. Adinolfi S., Bagni C., Castiglione Morelli M.A., Fraternali F., Musco G., and Pastore A. Novel RNA-binding motif: the KH module. Biopoly 51 (1999) 153-164
2. Baber J.L., Libutti D., Levens D., and Tjandra N. High precision solution structure of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K, a c-myc transcription factor. J. Mol. Biol. 289 (1999) 949-962
3. Bare L.A., Mansson E., and Yang D. Expression of two variants of the human mu-opioid receptor mRNA in SK-N-SH cells and human brain. FEBS 354 (1994) 213-216
4. Braddock D.T., Baber J.L., Levens D., and Clore G.M. Molecular basis of sequence-specific single-stranded DNA recognition by KH domains: solution structure of a complex between hnRNP K KH3 and single-stranded DNA. EMBO 21 (2002) 3476-3485
5. Collier B., Goobar-Larasson L., Sokolowski M., and Schwartz S. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogeneous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273 (1998) 22648-22656
6. Chen H., Hewison M., Hu B., and Adams J.S. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6109-6114
7. Denisenko O.N., and Bomsztyk K. Yeast hnRNP K-like genes are involved in regulation of the telomeric position effect and telomere length. Mol. Cell. Biol. 22 (2002) 286-297
8. Du Q., Melnikova I.N., and Gardner P.D. Differential effects of heterogeneous nuclear ribonucleoprotein K on Sp1- and Sp3-mediated transcriptional activation of a neuronal nicotinic acetylcholine receptor promoter. J. Biol. Chem. 273 (1998) 19877-19883
9. Expert-Bezancon A., Le Caer J.P., and Marie J. HnRNP K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken-beta-tropomyosin pre-mRNA. J. Biol. Chem. 277 (2002) 16614-16623
10. Gamarnik A.V., and Andino R. Two functional complexes formed by KH domain containing proteins with the 5′ noncoding region of poliovirus RNA. RNA 3 (1997) 882-892
11. Giles K.M., Daly J.M., Beveridge D.J., Thomson A.M., Voon D.C., Furneaux H.M., Jazayeri J.A., and Leedman P.J. The 3′-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein. J. Biol. Chem. 278 (2003) 2937-2946
12. Habelhah H., Shah K., Huang L., Ostareck-Lederer A., Burlingame A.L., Shokat K.M., Hentze M.W., and Ronai Z. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell Biol. 3 (2001) 325-330
13. Holcik M., and Liebhaber S.A. Four highly stable eukaryotic mRNAs assemble 3′ untranslated region RNA-protein complexes sharing cis and trans components. Proc. Natl. Acad. Sci. U. S. A. 95 (1997) 2410-2414
14. Ito K., Sato K., and Endo H. Cloning and characterization of a single-stranded binding protein that specifically recognizes deoxycytidine stretch. Nucleic Acid Res. 22 (1993) 53-58
15. Kawaguchi T., Kato S., Otsuka K., Watanabe G., Kumabe T., Tominaga T., Yoshimoto T., and Ishioka C. The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library. Oncogene 24 (2005) 6081-6976
16. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides-receptors for opioid peptides. Cell. Mol. Neurobiol. 15 (1995) 615-635
17. Kieffer B.L. Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 20 (1999) 19-26
18. Kieffer B.L., and Evans C.J. Opioid tolerance-in search of the holy grail. Cell 108 (2002) 587-590
19. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66 (2002) 285-306
20. Kim C.S., Hwang C.K., Choi H.S., Song K.Y., Law P.Y., Wei L.N., and Loh H.H. Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J. Biol. Chem. 279 (2004) 46464-46473
21. Kim S.S., Pandey K.K., Choi H.S., Law P.Y., Wei L.N., and Loh H.H. Poly C binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol. Pharm. 68 (2005) 729-736
22. Ko J.L., and Loh H.H. Single-stranded DNA-binding complex involved in transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 276 (2001) 788-795
23. Ko J.L., and Loh H.H. Poly C binding protein, a single-stranded DNA binding protein, regulates mouse μ-opioid receptor gene expression. J. Neurochem. 93 (2005) 749-761
24. Ko J.L., Minnerath S.R., and Loh H.H. Dual promoters of mouse mu-opioid receptor gene. Biochem. Biophy. Res. Commun. 234 (1997) 351-357
25. Ko J.L., Liu H.C., Minnerath S.R., and Loh H.H. Transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 273 (1998) 27678-27685
26. Ko J.L., Chen H.C., and Loh H.H. Differential promoter usage of mouse mu-opioid receptor gene during development. Mol. Brain Res. 104 (2002) 184-193
27. Ko J.L., Liu H.C., and Loh H.H. Role of an AP-2-like element in transcriptional regulation of mouse mu-opioid receptor gene. Mol. Brain Res. 112 (2003) 153-162
28. Koch T., Schulz S., Pfeiffer M., Klutzny M., Schroder H., Kahl E., and Hollt V. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273 (1998) 13652-13657
29. Korner M., Rattner A., Mauxion F., Sen R., and Citri Y. A brain-specific transcription activator. Neuron 3 (1989) 563-572
30. Kovarik A., Peat N., Wilson D., Gendler S.J., and Taylor-Papadimitriou J. Analysis of the tissue-specific promoter of the MUC1 gene. J. Biol. Chem. 268 (1993) 9917-9926
31. Krecic A.M., and Swanson M.S. hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 11 (1999) 363-371
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
33. Law P.Y., and Loh H.H. Regulation of opioid receptor activities. J. Pharmacol. Exp. Ther. 289 (1999) 607-624
34. Law P.Y., Wong Y.H., and Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 389-430
35. Law P.Y., Loh H.H., and Wei L.N. Insight into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 47 (2004) 300-311
36. Leffers H., Dejgaard K., and Celis J.E. Characterization of two major cellular poly(rC) binding human proteins, each containing three K-homologous (KH) domains. Eur. J. Biochem. 234 (1995) 447-453
37. Liang Y., and Carr L.G. Transcription of the mouse mu-opioid receptor gene is regulated by two promoters. Brain Res. 769 (1997) 372-374
38. Liang Y., Mestek A., Yu L., and Carr L.G. Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res. 679 (1995) 82-88
39. Liu H.C., and Towle H.C. Functional synergism between multiple thyroid hormone response elements regulates hepatic expression of the rat S14 gene. Mol. Endocrinol. 8 (1994) 1021-1037
40. Makeyev A.V., and Liebhaber S.A. The poly C binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8 (2002) 265-278
41. Mansour A., Fox C.A., Akil H., and Waston S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18 (1995) 22-29
42. Michael W.M., Eder P.S., and Dreyfuss G. The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein. EMBO 16 (1997) 3587-3598
43. Michelotti E.F., Michelotti G.A., Aronsohn A.I., and Levens D. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol. Cell. Biol. 16 (1996) 2350-2360
44. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., and Loh H.H. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9081-9085
45. Moles A., Kieffer B.L., and D'Amato F.R. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 304 (2004) 1983-1986
46. Ogata H., Inoue N., and Podolsky D.K. Identification of a goblet cell-specific enhancer element in the rat intestinal trefoil factor gene promoter bound by a goblet cell nuclear protein. J. Biol. Chem. 273 (1998) 3060-3067
47. Oosterhuis J.H., and van der Hoorn F.A. Testis-specific TTF-D binds to single-stranded DNA in the c-mos and Odf1 promoters and activates Odf1. J. Biol. Chem. 274 (1999) 11708-11712
48. Ostareck D.H., Ostarek-Lederer A., Wilm M., Thiele B.J., Mann M., and Hentze M.W. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 89 (1997) 597-606
49. Ostareck-Lederer A., Ostareck D.H., Cans C., Neubauer G., Bomsztyk K., Superti-Furga G., and Hentze M.W. c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol. Cell. Biol. 22 (2002) 4535-4543
50. Ostrowski J., Kawata Y., Schullery D.S., Denisenko O.N., and Bomsztyk K. Transient recruitment of the hnRNP K protein to inducibly transcribed gene loci. Nucleic Acid Res. 37 (2003) 3954-3962
51. Pan Y.X. Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants. Gene 295 (2002) 97-108
52. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14084-14089
53. Paziewska A., Wyrwicz L.S., Bujnicki J.M., Bomsztyk K., and Ostrowski J. Cooperative binding of the hnRNP K three KH domains to mRNA targets. FEBS Lett. 577 (2004) 134-140
54. Pecorino L.T., Darrow A.L., and Strickland S. In vitro analysis of the tissue plasminogen activator promoter reveals a GC box-binding activity present in murine brain but undetectable in kidney and liver. Mol. Cell. Biol. 11 (1991) 3139-3147
55. Rivera-Gines A., Cook R.J., Loh H.H., and Ko J.L. Interplay of Sps and Poly C binding protein 1 on the mu-opioid receptor gene expression. Biochem. Biophys. Res. Commun. 345 (2006) 530-537
56. Schoenherr C.J., and Anderson D.J. Silencing is golden: negative regulation in the control of neuronal gene transcription. Curr. Opin. Neurobiol. 5 (1995) 566-571
57. Siomi H., Choi M., Siomi M.C., Nussbaum R.L., and Dreyfuss G. Essential Role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77 (1994) 33-39
58. Solecki D., Schwarz S., Wimmer E., Lipp M., and Bernhardt G. The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity. J. Biol. Chem. 272 (1997) 5579-5586
59. Takimoto M., Tomonaga T., Matunis M., Avigan M., Krutzsch H., Dreyfuss G., and Levens D. Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. J. Biol. Chem. 268 (1993) 18249-18258
60. Tomonaga T., and Levens D. Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator. J. Biol. Chem. 270 (1995) 4875-4881
61. Walter B.L., Parsley T.B., Ehrenfeld E., and Semler B.L. Distinct poly(rC) binding protein KH domain determinants for poliovirus translation initiation and viral RNA replication. J. Virol. 76 (2002) 12008-12022
62. Zhong M., Henriksen M.A., Takeuchi K., Schaefer O., Liu B., ten Hoeve J., Ren Z., Mao X., Chen X., Shuai K., and Darnell Jr. J.E. Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3966-3971